Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 43, Issue 2, Pages 136-150Publisher
CELL PRESS
DOI: 10.1016/j.tips.2021.11.004
Keywords
-
Categories
Funding
- REPO-TRIAL project
- European Union [777111]
Ask authors/readers for more resources
For complex diseases, the traditional approach of drug discovery is highly ineffective. The shift towards systems and network medicine, along with the use of network pharmacology, revolutionizes the way we define, diagnose, and treat diseases. This approach focuses on causal, multitarget signaling modules, allowing for precise and effective therapeutic intervention through drug repurposing.
For complex diseases, most drugs are highly ineffective, and the success rate of drug discovery is in constant decline. While low quality, reproducibility issues, and translational irrelevance of most basic and preclinical research have contributed to this, the current organ-centri city of medicine and the 'one disease-one target-one drug' dogma obstruct innovation in the most profound manner. Systems and network medicine and their therapeutic arm, network pharmacology, revolutionize how we define, diagnose, treat, and, ideally, cure diseases. Descriptive disease phenotypes are replaced by endotypes defined by causal, multitarget signaling modules that also explain respective comorbidities. Precise and effective therapeutic intervention is achieved by synergistic multicompound network pharmacology and drug repurposing, obviating the need for drug discovery and speeding up clinical translation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available